Impact ledger
Vistagen Therapeutics, Inc. (VTGN)
2 events mapped to this ticker since 2026-06-30.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-06-30 | revenue | Bearish | — | 0.90 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-30 | Event | Direct clinical trial failure for primary and secondary endpoints, leading to significant doubt about fasedienol's broad market viability and regulatory approval pathway. | Bearish | 1-3m | 0.90 |
| 2026-06-30 | Event | Potential for fasedienol to be pursued for a subpopulation, requiring further clinical development and regulatory discussions, which could extend timelines and increase costs. | watch | 3-12m | 0.40 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for VTGN, start a trial or view the VTGN entity page.